Muiticentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer

F. Cappuzzo, F. Mazzoni, A. Gennari, S. Donati, B. Salvadori, C. Orlandini, G. L. Cetto, A. Molino, E. Galligioni, M. Mansutti, S. Tumolo, A. Lucentini, F. Valduga, S. Bartolini, L. Crinò, P. F. Conte

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Muiticentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences